(Q53299851)
Statements
A monoclonal antibody against HER-2 (trastuzumab) for metastatic breast cancer: a model-based cost-effectiveness analysis. (English)
1 reference
J Norum
1 reference
T Risberg
1 reference
J A Olsen
1 reference
22 April 2005
1 reference
16
1 reference
909-914
1 reference
6
1 reference
Identifiers
1 reference